Wait, so at one time this compound leronlimab (ccr5) could have been managed by real CEO, but it was turned down to take Fife financing? For what? So Nader could enrich himself along with the board of directors.
You only quote a Dollar amount, what was the corresponding share amount to get that size of funds raising ? That is what matters, especially to the question of dilution.